S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q2 2022

Deep Track Capital

Period: Q2 2022 Β· Filed: 2022-08-12
View on SEC EDGAR β†—
AUM
$1.52B
Total portfolio value
Positions
51
Reported securities
Top Holding
GBT
7.7% $116.5M
QoQ Changes
+6 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-08-12) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
GBTGLOBAL BLOOD THERAPEUTICS IN$116.5M7.66%β€”β€”
7.7%
NVCRNOVOCURE LTD$93.2M6.13%$69.50$17.20-75.3%
6.1%
TVTXTRAVERE THERAPEUTICS INC$86.8M5.70%$24.23$56.92+134.9%
5.7%
JAZZJAZZ PHARMACEUTICALS PLC$78.0M5.13%$156.01$243.47+56.1%
5.1%
ALNYCALLALNYLAM PHARMACEUTICALS INC$72.9M4.79%$145.85$312.78+114.5%
4.8%
KURAKURA ONCOLOGY INC$67.8M4.46%$18.33$11.10-39.4%
4.5%
MDGLMADRIGAL PHARMACEUTICALS INC$64.8M4.26%$71.58$528.10+637.8%
4.3%
KDNYCHINOOK THERAPEUTICS INC$60.0M3.94%β€”β€”
3.9%
BMRNBIOMARIN PHARMACEUTICAL INC$54.2M3.56%$82.87$58.99-28.8%
3.6%
FATEFATE THERAPEUTICS INC$50.0M3.29%$24.78$2.92-88.2%
3.3%
BCYCBICYCLE THERAPEUTICS PLC$48.7M3.20%$16.78$4.35-74.1%
3.2%
BEAMBEAM THERAPEUTICS INC$48.4M3.18%$38.71$34.79-10.1%
3.2%
ISEEIVERIC BIO INC$43.3M2.85%β€”β€”
2.9%
AGENAGENUS INC$43.1M2.84%$38.08$3.49-90.8%
2.8%
ESPRESPERION THERAPEUTICS INC NE$38.2M2.51%$6.36$3.16-50.3%
2.5%
RPTXREPARE THERAPEUTICS INC$37.9M2.49%β€”β€”
2.5%
NUVBNUVATION BIO INC$37.2M2.44%$3.24$5.70+75.9%
2.4%
IMVTIMMUNOVANT INC$36.9M2.42%$3.90$38.79+894.6%
2.4%
NKTXNKARTA INC$34.7M2.28%$12.32$3.22-73.9%
2.3%
NRIXNURIX THERAPEUTICS INC$30.9M2.03%$12.67$23.97+89.2%
2.0%
FMTXFORMA THERAPEUTICS HLDGS INC$27.9M1.83%β€”β€”
1.8%
TCDAQTRICIDA INC$26.4M1.74%β€”β€”
1.7%
ACADACADIA PHARMACEUTICALS INC$24.4M1.61%$14.09$25.97+84.3%
1.6%
DYNDYNE THERAPEUTICS INC$24.0M1.58%$6.87$23.07+235.8%
1.6%
FDMT4D MOLECULAR THERAPEUTICS IN$21.9M1.44%$6.98$13.00+86.3%
1.4%
KROSKEROS THERAPEUTICS INC$20.4M1.34%$27.63$11.26-59.3%
1.3%
CRNXCRINETICS PHARMACEUTICALS IN$19.6M1.29%$18.65$42.23+126.4%
1.3%
KALVKALVISTA PHARMACEUTICALS INC$17.9M1.18%$9.84β€”
1.2%
DICEDICE THERAPEUTICS INC$16.2M1.06%β€”β€”
1.1%
INZYINOZYME PHARMA INC$15.5M1.02%β€”β€”
1.0%

Quarter-on-Quarter Activity

Q2 2022 vs. Q1 2022

New Positions (6)

TickerIssuerNotionalSince Filing
BMRNBIOMARIN PHARMACEUTICAL INC$54.2M-28.8%
NRIXNURIX THERAPEUTICS INC$30.9M+89.2%
ACADACADIA PHARMACEUTICALS INC$24.4M+84.3%
INZYINOZYME PHARMA INC$15.5M
SDGRSCHRODINGER INC$14.8M
ACETADICET BIO INC$13.0M

Exited Positions (7)

TickerIssuerNotional
ENTAENANTA PHARMACEUTICALS INC$14.2M
RXDXPROMETHEUS BIOSCIENCES INC$9.3M
NKTRNEKTAR THERAPEUTICS$5.4M
NKTRNEKTAR THERAPEUTICS$2.7M
VERVVERVE THERAPEUTICS INC$2.3M
AUTLAUTOLUS THERAPEUTICS PLC$1.6M
RFLRAFAEL HLDGS INC$0.3M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
NUVBNUVATION BIO INC$31.1M+892.8%+75.9%
RLMDRELMADA THERAPEUTICS INC$6.7M+389.6%
FMTXFORMA THERAPEUTICS HLDGS INC$12.5M+144.0%
PTGXPUTPROTAGONIST THERAPEUTICS INC$-1.4M+75.7%
BEAMBEAM THERAPEUTICS INC$4.6M+63.7%-10.1%
AGENAGENUS INC$8.7M+58.9%-90.8%
GBTGLOBAL BLOOD THERAPEUTICS IN$36.7M+58.2%
BCYCBICYCLE THERAPEUTICS PLC$-32.8M+56.3%-74.1%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
SAGESAGE THERAPEUTICS INC$-16.8M-74.5%
ATYRATYR PHARMA INC$-4.7M-71.7%
KROSKEROS THERAPEUTICS INC$-54.6M-46.4%-59.3%
GRTSQGRITSTONE BIO INC$-8.1M-42.4%
CRNXCRINETICS PHARMACEUTICALS IN$-14.2M-31.7%+126.4%
PASGPASSAGE BIO INC$-5.0M-31.3%
VIGLVIGIL NEUROSCIENCE INC$-1.9M-20.8%
DICEDICE THERAPEUTICS INC$-7.7M-16.6%
← Back to Hedge Funds